These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34911501)
21. Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana. Ahorhorlu SY; Quashie NB; Jensen RW; Kudzi W; Nartey ET; Duah-Quashie NO; Zoiku F; Dzudzor B; Wang CW; Hansson H; Alifrangis M; Adjei GO Malar J; 2023 Feb; 22(1):58. PubMed ID: 36803541 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019. Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679 [TBL] [Abstract][Full Text] [Related]
23. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo. Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899 [TBL] [Abstract][Full Text] [Related]
24. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Espié E; Lima A; Atua B; Dhorda M; Flévaud L; Sompwe EM; Palma Urrutia PP; Guerin PJ Malar J; 2012 May; 11():174. PubMed ID: 22631564 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013. Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P Malar J; 2016 Jun; 15():331. PubMed ID: 27334876 [TBL] [Abstract][Full Text] [Related]
28. Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar. Rakotoarisoa MA; Fenomanana J; Dodoson BT; Andrianaranjaka VHI; Ratsimbasoa A Malar J; 2022 Nov; 21(1):331. PubMed ID: 36376921 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children. Falade CO; Dada-Adegbola HO; Ogunkunle OO; Oguike MC; Nash O; Ademowo OG Med Princ Pract; 2014; 23(3):204-11. PubMed ID: 24732940 [TBL] [Abstract][Full Text] [Related]
30. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
31. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544 [TBL] [Abstract][Full Text] [Related]
32. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania. Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial. Beavogui AH; Camara A; Delamou A; Diallo MS; Doumbouya A; Kourouma K; Bouedouno P; Guilavogui T; Dos Santos Souza S; Kelley J; Talundzic E; Fofana A; Plucinski MM Malar J; 2020 Jun; 19(1):223. PubMed ID: 32580771 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance. Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H Malar J; 2015 Aug; 14():325. PubMed ID: 26289949 [TBL] [Abstract][Full Text] [Related]
37. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
38. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. Four Artemisinin-Based Combinations (4ABC) Study Group PLoS Med; 2011 Nov; 8(11):e1001119. PubMed ID: 22087077 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Tinto H; Diallo S; Zongo I; Guiraud I; Valea I; Kazienga A; Kpoda H; Sorgho H; Ouédraogo JB; Guiguemdé TR; D'Alessandro U Trop Med Int Health; 2014 Apr; 19(4):469-75. PubMed ID: 24494602 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana. Mawuli MA; Amoah LE; Cui L; Quashie NB; Afrane YA Malar J; 2024 Feb; 23(1):40. PubMed ID: 38317164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]